Pakistan drug firm to import potential Covid-19 treatment from Bangladesh
ডেইলি স্টার
প্রকাশিত: ২৯ মে ২০২০, ১৮:৫৪
A pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from Bangladesh, it said in a stock exchange filing on Friday. The announcement by Searle Company Limited came a day after 56 virus deaths were recorded by the south Asian nation, its highest toll in a single day. The firm said it had